Yara International (YAR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
EBITDA excluding special items rose 38% year-over-year to $804M in Q3 2025, driven by higher margins, cost reductions, and strong operational performance, with record-high production and robust commercial execution.
Adjusted earnings per share YTD 2025 increased to $3.25 from $1.37 last year, and net income for the first nine months reached $1,028M, up from $306M.
Stable demand conditions in key markets, notably Brazil, with improved NPK sales and stable nitrogen imports year-over-year.
Strategic focus on U.S. clean ammonia projects, with investment decisions expected in the first half of next year and strict capital discipline maintained.
Portfolio optimization and organizational restructuring continued, with closures and divestments in France, Brazil, Belgium, and updated segment reporting.
Financial highlights
Revenue for Q3 2025 was $4,108M, up from $3,654M in Q3 2024; YTD revenue reached $11,703M, up from $10,515M.
EBITDA excluding special items increased from $585M in 3Q24 to $804M in 3Q25, with expanded margins in captive phosphate operations in Finland.
Free cash flow before financing activities reached $1,246M L12M, but was impacted by increased operating capital from higher prices and inventory build-up.
Net debt remained stable at $3,316M, with net debt/equity ratio improved to 0.39 from 0.47.
ROIC (annualized) improved to 12.6% in Q3 2025 from 8.9% in Q3 2024.
Outlook and guidance
Maintenance CapEx for 2026 expected at the higher end of $700–$850 million range due to major plant turnarounds.
Cost and capex reduction program ahead of schedule, targeting $180M in annual fixed cost savings by Q4 2025.
Capex guidance for 2025 reduced to $1.1B, $250M lower than original, reflecting capital discipline.
U.S. blue ammonia project investment decision timeline remains first half of next year, with double-digit return threshold.
No major one-off effects anticipated in Q4; focus remains on volume flow and cash flow optimization.
Latest events from Yara International
- EBITDA up 39% to $906M in Q2 2026; major ammonia acquisition boosts strategy and outlook.YAR
Q2 202617 Jul 2026 - EBITDA up 47% YoY to USD 638m; net income and margins rise amid cost reductions.YAR
Q1 20259 Jul 2026 - EBITDA up 47% to $585M; net income $286M; margins strong but market volatility persists.YAR
Q3 20248 Jul 2026 - Strong early demand, urea price surge, and updated CBAM sensitivities shape 1Q26 outlook.YAR
Pre-Close Call Presentation6 Jul 2026 - Market volatility, plant outages, and cost reductions shape 2Q 2026 outlook; results due July 17.YAR
Pre-Close Call Presentation6 Jul 2026 - $1.3B Texas ammonia plant deal boosts capacity, cost efficiency, and U.S. market position.YAR
M&A announcement2 Jul 2026 - EBITDA excluding special items jumped 41% year-over-year to $896M amid global market volatility.YAR
Q1 202624 Apr 2026 - EBITDA excluding special items rose 37% to $709M in Q4, with strong cash flow and dividend proposal.YAR
Q4 202516 Apr 2026 - Operational strengths and strategic partnerships underpin ambitious financial and sustainability goals.YAR
SB1 Markets Energy Conference presentation25 Feb 2026